In the media Archives - TMC

Services
From Phase 0 exploratory clinical trials to Phase V post-market safety monitoring, we provide a full range of services covering all phases of clinical research.
Our drug development solutions simplify complex pathways, helping you scale clinical operations and drive your innovative therapy to market (and the patients who need it) as quickly and cost-effectively as possible.
Regulatory
Pharmacovigilance
Clinical
Medical
About Us
TMC is a global clinical research organisation supporting small-to-medium biotech and biopharmaceutical companies through all phases of clinical research.
Our in-house experts and network of highly skilled associates deliver a complete range of flexible, integrated and tailored drug development solutions that span clinical development, consulting and functional execution for clinical studies and post-approval commercialisation.
Our Purpose
Our Leadership Team
Our Associates
Our Partnerships
Our ESG
Testimonials
Resources
News & Events
- News
- Events
Careers with TMC
- Join Our Team
- Join Our Network
Contact Us
- Office location EU

Taking an inquirer-centric approach to rare disease medical information

By TMC|2025-06-25T15:51:55+01:0025 June 2025|In the media|0 Comments

The importance of incorporating decentralised clinical trials (DCTS) and patient centricity by design in rare disease studies

By TMC|2025-06-25T14:41:10+01:0027 May 2025|In the media|0 Comments

Navigating the complexity of compliance review of UK/EU product communications for rare diseases

By Marcelo Vaz, Vice President of Medical Services at [...]

By TMC|2025-06-25T14:41:58+01:0010 March 2025|In the media|0 Comments

TMC Pharma champions holistic approach to medical services in rare disease drug development
Gallery
TMC Pharma champions holistic approach to medical services in rare disease drug development
In the media

TMC Pharma champions holistic approach to medical services in rare disease drug development

By TMC|2024-11-08T15:31:31+00:0015 March 2024|In the media|0 Comments

European Biopharmaceutical Review article 29 February 2024
Gallery
European Biopharmaceutical Review article 29 February 2024
In the media

European Biopharmaceutical Review article 29 February 2024

By TMC|2024-11-08T15:32:02+00:006 March 2024|In the media|0 Comments

Clinical Trials Arena article 29 February 2024
Gallery
Clinical Trials Arena article 29 February 2024
In the media

Clinical Trials Arena article 29 February 2024

By TMC|2024-11-08T15:32:09+00:001 March 2024|In the media|0 Comments

PharmaTimes article 29 February 2024
Gallery
PharmaTimes article 29 February 2024
In the media

PharmaTimes article 29 February 2024

By TMC|2024-11-08T15:32:13+00:001 March 2024|In the media|0 Comments